COMMUNIQUÉS West-GlobeNewswire

Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
14/05/2026
-- Zola ® volumes increase 18% year-over-year -- -- SG&A at lowest level in Arcadia’s history -- DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc . ® (Nasdaq: RKDA), a producer and marketer of [...]
BioStem Technologies Reports First Quarter 2026 Financial Results
14/05/2026
POMPANO BEACH, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue [...]
RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter
14/05/2026
Q1 2026 Revenue of $563,000 Totals Over 50% of Full Year 2025 Total Revenue Active Commercial Cancer Center Customers Expand to 16 with Growing Sales Pipeline, Accelerating Adoption of the TAMP™ Therapy Platform Enabled [...]
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
14/05/2026
Q1 2026 product sales of $24.3 million, representing 73% growth over Q1 2025 Raising full year revenue guidance - now expect 2026 revenue to exceed $120 million, up from previous guidance of $110 million Q1 2026 fully [...]
Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results
14/05/2026
Strengthened balance sheet and advancing clinical pipeline with multiple catalysts expected through 2027 SOLANA BEACH, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “ [...]
Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting
14/05/2026
In preclinical studies of CSU, Bexobrutideg demonstrates potent BTK degradation across key immune cell types and enhanced suppression of FcεRI-driven pathology versus remibrutinib In healthy volunteers, both single- and [...]
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments
14/05/2026
Moves designed to strengthen leadership and financial position, advance portfolio, and leverage expertise in precision immunoengineering Enhanced the company’s portfolio with an exclusive license for, CUE-221, a Phase 2 [...]
Adaptin Bio Shares (Ticker: APTN) Commence Trading on the OTCQB
14/05/2026
CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio , Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer therapeutics enabled by targeted delivery to the [...]
Award-Winning Film ‘An Inconvenient Study’ Being Blocked By Verizon
14/05/2026
ICAN Investigates Reports That Verizon Customers Are Unable to Access AnInconvenientStudy.com AUSTIN, Texas, May 14, 2026 (GLOBE NEWSWIRE) -- Informed Consent Action Network (ICAN) is investigating mounting reports from [...]
Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
14/05/2026
WILMETTE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet [...]
Historical DNA connects 1.3 million living relatives to 17th-century Maryland settlers and may have identified the colony’s second governor
14/05/2026
Analysis of Historic St. Mary’s City highlights the power of combining ancient DNA, archaeology, and genealogy to restore lost identities and track the migrations of America's earliest English colonists and their [...]
AdCare Rhode Island Among Few in the Northeast Offering Accelerated Methadone Detox
14/05/2026
NORTH KINGSTOWN, R.I., May 14, 2026 (GLOBE NEWSWIRE) -- AdCare Rhode Island, a leading provider of addiction treatment services, is among a select group of facilities in the Northeast offering an accelerated methadone [...]
Lanier Recovery Center opens its doors in Suwanee, Georgia, bringing comprehensive addiction treatment to the Atlanta region
14/05/2026
Lanier Recovery Center opens in Suwanee to give Atlanta-area individuals and families a trusted local resource for addiction treatment and mental health care. Suwanee, GA, May 14, 2026 (GLOBE NEWSWIRE) -- Lanier [...]
Rarecells Recognized Among Top 5 Disruptive Health Technologies with the Potential to Change the World by Maynooth University’s Innovation Value Institute
14/05/2026
NEW YORK and PARIS, May 14, 2026 (GLOBE NEWSWIRE) -- Rarecells, a pioneer in liquid biopsy technologies for early cancer detection, today announced that its proprietary ISET® diagnostic system has been recognized by the [...]
Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026
14/05/2026
100% of patients treated with CTA313 achieved an SRI-4 response, with half achieving remission BOSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage biotechnology company developing next-generation [...]
Terumo Neuro Announces Publication of Landmark RAGE Study Results for HydroCoil™ Embolic System Coils for Ruptured Intracranial Aneurysms
14/05/2026
Largest prospective, core lab–adjudicated trial in North America confirms strong occlusion, low rebleeding, and favorable functional independence Aliso Viejo, CA, May 14, 2026 (GLOBE NEWSWIRE) -- Terumo Neuro, a global [...]
DentPrime Introduces an “International Complication Protection Program” for Overseas Dental Patients
14/05/2026
New initiative to increase patient confidence and long-term aftercare support in international dental treatment ANTALYA, Türkiye, May 14, 2026 (GLOBE NEWSWIRE) -- As dental tourism grows internationally for patients [...]
Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
14/05/2026
Company announcement No. 16 / 2026 Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026) Copenhagen, Denmark, May 14, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
Tessera Therapeutics Showcases New Preclinical Data Advancing In Vivo Program in Sickle Cell Disease and CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting
14/05/2026
Presented improved editing data in non-human primates (NHP) for sickle cell disease (SCD), demonstrating a single dose of Gene Writer achieved an average of 85% of long-term hematopoietic stem cells (LT-HSCs) with at [...]

Pages